Home » Glaxo Sells Bad With Good in Safety Push Amid China Woes
Glaxo Sells Bad With Good in Safety Push Amid China Woes
GlaxoSmithKline is intent on selling its new lung drug, Breo, amid a massive bribery scandal still playing out in China.
Bloomberg
Bloomberg
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May